Boston Megan 4
4 · Benitec Biopharma Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2023-06-13+153,000→ 153,000 totalExercise: $0.23Exp: 2033-06-13→ Common Stock (153,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026.